QuidelOrtho Corporation/$QDEL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
Ticker
$QDEL
Sector
Primary listing
Employees
6,500
Headquarters
Website
QDEL Metrics
BasicAdvanced
$964m
-
-$17.81
0.74
-
Price and volume
Market cap
$964m
Beta
0.74
52-week high
$35.58
52-week low
$9.92
Average daily volume
2.1m
Financial strength
Current ratio
1.431
Quick ratio
0.652
Long term debt to equity
141.255
Total debt to equity
155.272
Interest coverage (TTM)
0.26%
Profitability
EBITDA (TTM)
491.7
Gross margin (TTM)
45.18%
Net profit margin (TTM)
-45.57%
Operating margin (TTM)
1.79%
Effective tax rate (TTM)
-2.76%
Revenue per employee (TTM)
$410,000
Management effectiveness
Return on assets (TTM)
0.51%
Return on equity (TTM)
-49.95%
Valuation
Price to revenue (TTM)
0.361
Price to book
0.52
Price to tangible book (TTM)
-1.44
Price to free cash flow (TTM)
-5.289
Free cash flow yield (TTM)
-18.91%
Free cash flow per share (TTM)
-2.672
Growth
Revenue change (TTM)
-3.89%
Earnings per share change (TTM)
234.05%
3-year revenue growth (CAGR)
-5.11%
10-year revenue growth (CAGR)
30.70%
3-year earnings per share growth (CAGR)
112.40%
10-year earnings per share growth (CAGR)
45.94%
What the Analysts think about QDEL
Analyst ratings (Buy, Hold, Sell) for QuidelOrtho Corporation stock.
QDEL Financial Performance
Revenues and expenses
QDEL Earnings Performance
Company profitability
QDEL News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs